The intensive care medicine agenda on acute kidney injury
- PMID: 28138736
- PMCID: PMC5534380
- DOI: 10.1007/s00134-017-4687-2
The intensive care medicine agenda on acute kidney injury
Abstract
Acute kidney injury (AKI) is a common complication in the critically ill. Current standard of care mainly relies on identification of patients at risk, haemodynamic optimization, avoidance of nephrotoxicity and the use of renal replacement therapy (RRT) in established AKI. The detection of early biomarkers of renal tissue damage is a recent development that allows amending the late and insensitive diagnosis with current AKI criteria. Increasing evidence suggests that the consequences of an episode of AKI extend long beyond the acute hospitalization. Citrate has been established as the anticoagulant of choice for continuous RRT. Conflicting results have been published on the optimal timing of RRT and on the renoprotective effect of remote ischaemic preconditioning. Recent research has contradicted that acute tubular necrosis is the common pathology in AKI, that septic AKI is due to global kidney hypoperfusion, that aggressive fluid therapy benefits the kidney, that vasopressor therapy harms the kidney and that high doses of RRT improve outcome. Remaining uncertainties include the impact of aetiology and clinical context on pathophysiology, therapy and prognosis, the clinical benefit of biomarker-driven interventions, the optimal mode of RRT to improve short- and long-term patient and kidney outcomes, the contribution of AKI to failure of other organs and the optimal approach for assessing and promoting renal recovery. Based on the established gaps in current knowledge the trials that must have priority in the coming 10 years are proposed together with the definition of appropriate clinical endpoints.
Keywords: Acute kidney injury; Biomarkers; Fluid therapy; Renal replacement therapy; Research agenda; Trial endpoints.
Conflict of interest statement
MS declares no conflicts of interest.
Figures




Similar articles
-
Acute kidney injury in sepsis.Intensive Care Med. 2017 Jun;43(6):816-828. doi: 10.1007/s00134-017-4755-7. Epub 2017 Mar 31. Intensive Care Med. 2017. PMID: 28364303 Review.
-
Acute Kidney Injury in the Critically Ill Patient: A Current Review of the Literature.J Intensive Care Med. 2016 Jun;31(5):319-24. doi: 10.1177/0885066615575699. Epub 2015 Mar 9. J Intensive Care Med. 2016. PMID: 25752308 Review.
-
Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis.Crit Care. 2021 Jan 6;25(1):15. doi: 10.1186/s13054-020-03451-y. Crit Care. 2021. PMID: 33407756 Free PMC article.
-
[The timing of renal replacement therapy on mortality in patients with acute renal injury: a reanalysis of two recently published randomized control trials].Zhonghua Nei Ke Za Zhi. 2018 May 1;57(5):355-357. doi: 10.3760/cma.j.issn.0578-1426.2018.05.010. Zhonghua Nei Ke Za Zhi. 2018. PMID: 29747292 Chinese.
-
Effects of renal replacement therapy on renal recovery after acute kidney injury.Nephron Clin Pract. 2014;127(1-4):35-41. doi: 10.1159/000363671. Epub 2014 Sep 24. Nephron Clin Pract. 2014. PMID: 25343818 Review.
Cited by
-
Evaluation of Urinary NGAL as a Diagnostic Tool for Acute Kidney Injury in Critically Ill Patients With Infection: An Original Study.Can J Kidney Health Dis. 2020 Jun 19;7:2054358120934215. doi: 10.1177/2054358120934215. eCollection 2020. Can J Kidney Health Dis. 2020. PMID: 32612844 Free PMC article.
-
Acute kidney injury in sepsis.Intensive Care Med. 2017 Jun;43(6):816-828. doi: 10.1007/s00134-017-4755-7. Epub 2017 Mar 31. Intensive Care Med. 2017. PMID: 28364303 Review.
-
Risk prediction for severe acute kidney injury by integration of urine output, glomerular filtration, and urinary cell cycle arrest biomarkers.Crit Care Resusc. 2020 Jun;22(2):142-151. doi: 10.51893/2020.2.oa4. Crit Care Resusc. 2020. PMID: 32389106 Free PMC article.
-
Continuous diffusion spectrum computation for diffusion-weighted magnetic resonance imaging of the kidney tubule system.Quant Imaging Med Surg. 2021 Jul;11(7):3098-3119. doi: 10.21037/qims-20-1360. Quant Imaging Med Surg. 2021. PMID: 34249638 Free PMC article.
-
The Furosemide Stress Test: A Dynamic Tool for Predicting Acute Kidney Injury Progression in Critical Care Medicine.J Clin Med. 2025 Apr 10;14(8):2595. doi: 10.3390/jcm14082595. J Clin Med. 2025. PMID: 40283425 Free PMC article. Review.
References
-
- Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–R212. - PMC - PubMed
-
- Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury: AKI definition. Kidney Intern Suppl. 2012;2:19–36.
-
- Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–1399. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical